DMII

Drugs Made In America Acquisition Ii Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 2/10
  • Value↓ 0/10
Drugs Made In America Acquisition Ii sales and earnings growth
DMII Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Drugs Made In America Acquisition Ii gross and profit margin trends
DMII Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Drugs Made In America Acquisition Ii net debt vs free cash flow
DMII Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Drugs Made In America Acquisition Ii stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Shell Companies stocks ↗